Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opsens Inc V.OPS


Primary Symbol: T.OPS

OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.


TSX:OPS - Post by User

Bullboard Posts
Post by Robr15on Nov 08, 2018 1:40pm
103 Views
Post# 28945175

more news not that it seems to matter

more news not that it seems to matterReturn to news

Quebec City, Quebec, November 8, 2018 – Opsens Inc. (“Opsens”) (TSX:OPS) (OTCQX:OPSSF) announces that its Diastolic Pressure Ratio called dPR, has been used for the first time by Dr. Hitoshi Matsuo, cardiologist and President of the Gifu Heart Center Japan.

The measurement of Fractional Flow Reserve (“FFR”) as a method of assessing intracoronary pressure has gained credibility and popularity following the publication of clinical studies demonstrating its benefits for patients’ health. FFR is used to assess the incidence of coronary artery stenosis before selecting a treatment. This measurement is taken in the context where the heart is stimulated. Opsens’ dPR has been developed to answer the need cardiologists have expressed to measure intracoronary pressure to make a diagnosis with the heart at rest.

“The arrival of Opsens’ dPR is exciting for interventional cardiologists who need reliable measurements to assess and treat patients with the heart at rest,” said Dr. Matsuo. “Second generation fiber optic technology enables accuracy which is becoming even more critical when pressure over coronary lesions is measured in a resting situation. In our experience, Opsens’ OptoWire has the lowest drift in the industry and paired with the dPR, it stands out for its accuracy and ease of use. I felt very comfortable with my diagnosis. I could also re-use the technology after stenting to measure the success of the procedure,” Dr. Matsuo added.

“Dr. Matsuo is a recognized key opinion leader in Japan and around the world. We are very honored by his trust to be the first worldwide user of Opsens’ dPR algorithm,” said Louis Laflamme, Opsens’ President and Chief Executive Officer. “Our customers have shown growing interest in assessing intracoronary pressure with the heart at rest while asking for an alternative to existing resting algorithm. I am proud of our team’s hard work that provided interventional cardiologists with this alternative,” Laflamme added.

Medical publications have highlighted the equivalence of several algorithms using the measurement of pressure at rest. These publications are expected to accelerate the adoption of resting pressure measurement methods in the Interventional Cardiology community.

 
Bullboard Posts